Shawn Morales

Shawn Morales is a Senior Clinical Research Scientist at Skye Bioscience Inc. since August 2024, with a robust background in clinical research and drug development. Previously, Shawn served as Principal Scientist at Aurinia Pharmaceuticals Inc. (January 2021 - May 2024), leading biologics programs to IND submission and managing external data flow, resulting in early completion of reports and earning the Aurinia Award of Excellence. Prior roles include Senior Scientist positions at Aurinia Pharmaceuticals and Arrowhead Pharmaceuticals, specializing in siRNA therapeutics and fibrosis, where Shawn drove experimental studies and developed strategic partnerships with key CROs. Shawn's career began at Allergan, focusing on biologics and assay development. Educational credentials include a PhD in Cellular and Molecular Pathology from UCLA and a Bachelor of Science in Microbiology and Immunology from UC San Diego, along with certification as an NCA Analyst from Certara University.